PTGS2 (COX-2), an enzyme induced by pro-inflammatory cytokines, releases prostaglandin E2 (PGE2) and promotes the synthesis of prostaglandins stimulating cancer cell proliferation, development, and metastasis; thus, it serves as a therapeutic target for anti-inflammatory drugs. The gene discussed is PTGS2; the disease is cancer.